Search

Dr. Heng will be presenting a poster, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer" at the 2024 Harvard Institute of RNA Medicine Symposium.

Dr Gerburg Wulf will be presenting a talk and poster for the team at the Basser Center for BRCA Scientific Symposium, "Early eradication of BRCA1/2mut tumors."

“ Toker Cell Hyperplasia in the Nipple-areolar Complex of Transmasculine Individuals”, published in Modern Pathology, has been selected as Best Clinical Paper 2023 by the BIDMC Cancer Research Institute.

The Heng/Wulf team abstract, "Biological sex-linked immune modulation but not cross-sex estrogen therapy reduces the efficacy of PARP inhibition in the treatment of Brca1 breast tumors" has been selected for Poster Spotlight presentation at the SABCS 2024.

Leveraging an artificial intelligence algorithm created by Dr. Heng's team to analyze breast tissue composition—the relative amounts of breast epithelium, fibrous stroma, and fat—the findings suggest that gender-affirming testosterone therapy may decrease the breast cancer risk for trans masculine...

Dr Heng will be an invited panelist for the session, “The clinical and scientific promise of machine learning and artificial intelligence”, at the BIDMC Research Retreat in Fall 2024. She will talk about the machine learning methods she used to create prognostic signatures, as well as the artificial...